title: Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis.
abstract: To examine whether polymorphism at the SAA loci is associated with the development of amyloid protein A (AA)-amyloidosis, we determined the genotypes at the SAA1 and SAA2 loci in 43 AA-amyloidosis patients (amyloidosis population) and 77 patients with rheumatoid arthritis (RA) who had been ill for less than 5 years (early RA population). We also compared the frequencies of the genotypes at the SAA1 locus among 90 Korean, 95 Taiwanese, and 103 Japanese healthy subjects. The frequencies of the gamma/gamma genotype and gamma alleles at the SAA1 locus were significantly higher in the amyloidosis population than in the early RA population (34.9% versus 7.8%, and 58.1% versus 33.8%, chi2 test P=0.0001). The frequencies of the gamma allele at the SAA1 locus in Koreans, Taiwanese, and Japanese were 41.6%, 35.6%, and 37.4%, respectively. The length of the latent period of AA-amyloidosis was significantly longer in the patients with smaller numbers of the gamma allele at the SAA1 locus (Spearman's correlation coefficient: -0.42, P<0.05). On the other hand, the mean C-reactive protein (CRP) level during 2 years prior to the diagnosis of AA-amyloidosis was significantly higher in the patients with larger numbers of the gamma allele at the SAA1 locus (Spearman's correlation coefficient: 0.34, P<0.05). No significant association was found between amyloidosis and polymorphism at the SAA2 locus. We postulate that the allele SAA1gamma renders an RA patient susceptible to amyloidosis, possibly by affecting the severity of inflammation in RA.
authors.affiliation: Institute of Rheumatology, Tokyo Women's Medical University, School of Medicine, Japan. mmorigu@aol.com
authors.forename: M
authors.initials: M
authors.lastname: Moriguchi
authors.forename: C
authors.initials: C
authors.lastname: Terai
authors.forename: Y
authors.initials: Y
authors.lastname: Koseki
authors.forename: M
authors.initials: M
authors.lastname: Uesato
authors.forename: A
authors.initials: A
authors.lastname: Nakajima
authors.forename: S
authors.initials: S
authors.lastname: Inada
authors.forename: M
authors.initials: M
authors.lastname: Nishinarita
authors.forename: S
authors.initials: S
authors.lastname: Uchida
authors.forename: A
authors.initials: A
authors.lastname: Nakajima
authors.forename: S Y
authors.initials: SY
authors.lastname: Kim
authors.forename: C L
authors.initials: CL
authors.lastname: Chen
authors.forename: N
authors.initials: N
authors.lastname: Kamatani
mesh_terms: D000328:Adult; D000368:Aged; D000483:Alleles; D000686:Amyloidosis / Q000209:etiology* / Q000235:genetics*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000235:genetics*; D001483:Base Sequence; D016022:Case-Control Studies; D017931:DNA Primers / Q000235:genetics; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D000685:Serum Amyloid A Protein / Q000235:genetics*; D013997:Time Factors
chemical_list: D017931:DNA Primers; C083772:SAA2 protein, human; D000685:Serum Amyloid A Protein